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ABSTRCT
OBJECTIVE: The objective of this selective EBM review is to determine whether or
not cognitive behavioral therapy (CBT) is effective in reducing depressive and manic
symptoms in people with bipolar disorder when compared to TAU.
STUDY DESIGN: Systematic review of three randomized controlled trials published in
2011, 2012, and 2014.
DATA SOURCES: Data sources for this review were articles published in peerreviewed journals using PubMed and Cochrane Collaboration.
OUTCOME(S) MEASURED: The outcomes measured were a decrease in depressive
and manic symptoms through the use of rating scales.
RESULTS: Costa et al. (2011) showed a greater decrease in depressive and manic
symptoms with cognitive behavioral therapy than with treatment as usual (p<0.01). West
et al. showed a reduction in depressive (p<0.007) and manic (p<0.03) symptoms with
CBT compared to the control group receiving general psychotherapy as well as a NNT of
2 for mania. Finally, Costa et al. (2012) showed a greater decrease in depressive and
manic symptoms with CBT than TAU (p<0.01). In total, each study showed a greater
reduction in depressive than manic symptoms.
CONCLUSIONS: All studies evaluated in this EBM review showed that CBT is
effective at reducing depressive and manic symptoms associated with bipolar disorder.
Major limitations of the study were the sample sizes and the fact none of the participants
included had severe depressive or manic symptoms. Further studies are needed to
conclude that CBT is effective for bipolar disorder.
KEY WORDS: Bipolar disorder, Cognitive behavioral therapy
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INTRODUCTION
Bipolar disorder is a chronic or episodic mental disorder that can cause unusual, often
extreme and fluctuating changes in mood, energy, activity, and concentration or focus.1 Bipolar
disorder affects approximately 2.8% (estimated 7 million people) adult Americans per year in the
United States.2 An exact number for the total healthcare cost of all three types of bipolar disorder
has not been identified. It is estimated that in 2015, $202.1 billion (averaging to $81,559 per
individual) was spent for bipolar disorder I.3 There is no current information on the number of
healthcare visits per year but between 2002-2003 there had been 1,003 visits per 100,000
population.4 Due to the growing recognition of mental health disorders, bipolar disorder is not
uncommon to see across any specialty.
The exact cause of bipolar disorder is unknown. However, research suggests that a
combination of factors contribute to bipolar disorder including stress, genes, and brain structure
and function.1 There are three types of bipolar disorder: bipolar I, bipolar II, and cyclothymic.
Each type involves a change in mood, energy, and activity level alternating with a normal
(euthymic) mood.1 Suicide is the number one cause of premature death among people with
bipolar disorder.5
While there is no curative treatment for bipolar disorder, there are several pharmacologic
and non-pharmacologic methods that are used to control and maintain the depressive and manic
symptoms that are associated. Pharmacologic treatments include mood stabilizers (i.e. lithium,
valproic acid, and lamotrigine), antidepressants (i.e. bupropion, fluoxetine, and sertraline), and
anxiolytics (i.e. lorazepam and clonazepam). Psychotherapy may include CBT, family therapy,
interpersonal therapy, and psychoeducation. For severe or refractory cases, electroconvulsive
therapy (ECT) may be used. Other non-pharmacological methods target lifestyle management
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including regular vigorous exercise (i.e., jogging, swimming, and biking) and keeping a life chart
with daily mood, treatments, sleep patterns, and life events.
The treatment options mentioned above all play an effective role in treating bipolar
disorder. However, with medications being a primary treatment, patients respond and tolerate
each differently. The use of medications also carries out the risks of various side effects and
potentially serious adverse reactions. In addition, the use of medications for a long period of time
may lead to tolerance and eventual drug resistance which further increases the risk of relapses.
While the use of medications may carry risks, the use of CBT has been shown to be effective in
reducing depression and mania associated with bipolar disorder and does not have serious side
effects like current treatments. Individual studies have shown CBT to be an effective method of
treatment for bipolar disorder, but a comprehensive analysis has not been done. This paper
evaluates three randomized controlled trials comparing the efficacy of cognitive behavioral
therapy (CBT) in reducing depressive and manic symptoms in people with bipolar disorder with
treatment as usual (TAU).
OBJECTIVE
The objective of this EBM review is to determine whether or not cognitive behavioral
therapy is effective in reducing depressive and manic symptoms in people with bipolar disorder
when compared to TAU. Hypothesis about the objective is that the use of CBT is effective in
reducing depressive and manic symptoms in people with bipolar disorder when compared to
TAU.
METHODS
The criteria used included the population, interventions, comparisons, outcomes
measured, and the types of studies included. The population included people, both male and
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female, with bipolar disorder. The intervention used was cognitive behavioral therapy (CBT).
The comparison used was treatment as usual (TAU) which includes both medications and
psychotherapy. The outcomes measured was the efficacy of CBT for the treatment of depression
and mania associated with bipolar disorder based on various rating scales given and evaluated by
the investigator. The studies included in this EBM review include three randomized controlled
trials.
PubMed and Cochrane Collaboration were used in order to find the articles used for this
systematic review. Articles were selected based on their relevance to the clinical question and if
the outcomes of the study mattered to the patients. All articles were published in peer-reviewed
journals within the past 10 years. The key words “bipolar disorder” and “cognitive behavioral
therapy” were used to search for the articles. All articles were published in English. The
inclusion criteria included articles that were randomized controlled trials, full text, published in
the last 10 years, English, and Child: birth-18 years. Exclusion criteria included studies that were
published before 2010. Table 1 further discusses inclusion and exclusion criteria from each
study. Statistics were reported using mean change from baseline, p-values, and NNT.
OUTCOMES MEASURED
The outcomes measured in Costa et al. (2011) and Costa et al. (2012) studied the patient
perception of reduction in depressive and manic symptoms based on the total severity of the selfreported rating scales, Beck Depression Inventory (BDI) and Young Mania Rating Scale
(YMRS). The BDI has 21 questions with ratings between 0-3. The patient fills out the
questionnaire and then the total score is added up and then correlated with a level of depression.
The YMRS has 11 questions with ratings between 0-4 with the same procedure as the BDI. The
outcomes measured in West et al. studied the parent perception of reduction in depressive and
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manic symptoms in pediatric patients based on the total severity of the rating scales, Child
Bipolar Depression Rating Scale (CBDRS) and Child Mania Rating Scale (CMRS). The CMRS
has 21 questions with the rating between 0-3, that is filled out by the parent, and the total score is
added up and compared to a mania scale determining the severity. The CBDRS is similar to
CMRS but measures the level of depression. For each rating scale, a higher score indicates more
severe disease. The study conducted by West et al. focused specifically on children while the
other two studies focused on patients 18 years and older. In all three studies, the CBT group was
compared to the TAU group.
RESULTS
In the study conducted by Costa et al. (2011), 41 subjects were recruited from an Anxiety
and Depression Program Outpatient Clinic in Rio de Janeiro. Subjects were studied over a period
of 14 weeks while receiving CBT for depressive and manic symptoms related to bipolar
disorder.6 Each subject in the CBT group attended two-hour sessions per week prescribed by an
experienced clinical psychologist trained in CBT.6 Each subject in the control group attended
sessions prescribed by their psychiatrists.6
The BDI for the CBT group showed a decrease in symptom score by an average of 12.28
which correlates with an improvement in depressive symptoms. The BDI for the control group
showed an increase in symptom score by an average of -2.25 which correlates with no
improvement or worsening depression.
The YMRS for the CBT group showed a decrease in symptoms score by an average of
7.44 which correlated with an improvement in manic symptoms. The YMRS for the control
group showed an increase in symptom score by an average of -1.59 which correlates with no
improvement or worsening mania.
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Table 1. Demographics & Characteristics of Included Studies
Study Type # Pts Age
Inclusion
Exclusion
(yrs) Criteria
Criteria
6
Costa RCT 41
18-60 -Met DSM-IV
BDI score >34
(2011)
criteria for BD I and a YMRS
or II and
>20 or presented
experienced at
a comorbid
least one
personality d/o
hypomanic,
and/or other axis
manic or
I severe psych
depressive
d/o
episode in
previous 12
months
-Euthymic,
mildly depressed
or mildly
hypomanic at the
time of initial
assessment
7
West
RCT 69
7-13
Stabilized on
Youth IQ <70,
(2014)
medication,
active psychosis,
parental consent, active substance
youth assent
abuse/
dependence,
neurological or
other medical
problems that
complicate psych
symptoms,
active suicidality
resulting in
hospitalization
8
Costa RCT 41
18-55 Men and women BDI >35 and/or
(2012)
aged 18-60 who YMRS >20,
met DSM-IV for comorbid
BD I or II and
personality d/o
experienced at
and/or other axis
least one
I severe psych
hypomanic,
d/o; substance
manic or
abuse/
depressive
dependence;
episode in
severe psychical
previous 12
illness; new
months
mood stabilizer
or antidepressant

W/D

Interventions

4

TAU attended
sessions
prescribed by
psychiatrist,
no
psychotherapy
VS.
14 cognitive
behavioral
group therapy
sessions
divided into
two stages, 2
hours each

22

Each group:
12 weekly
sessions and 6
monthly
follow up
sessions
Untrained in
CFF-CBT
VS. Trained
in CFF-CBT

4

Therapy
sessions
prescribed by
psychiatrist
VS.
14 group
cognitive
behavioral
therapy
weekly
sessions, 2
hours each, 2
phases
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The authors found that this greater decrease of depressive and manic symptoms with
CBT was statistically significant at p<0.01.6 The study reports that the data was analyzed using
the Pearson chi-square tests, ANOVA, paired-sample t-test, and a multiple regression analysis.6
They reported that CBT was well tolerated by most of the subjects with only one subject from
the CBT group requiring hospitalization for reasons not discussed.6
Table 2. Mean (SD) BDI changes at 7 Weeks and 14 Weeks from Baseline in Costa et al.
2011
Baseline: Mean Week 7: Mean Week 14: Mean Mean change
(SD)
(SD)
(SD)
from baseline
CBT group
19.52 (9.79)
12.00 (7.90)
7.24 (6.42)
12.28, p <0.01
Control group
11.67 (8.39)
12.58 (8.36)
13.92 (9.17)
-2.25, p <0.01
Table 3. Mean (SD) YMRS Changes at 7 Weeks and 14 Weeks from Baseline in Costa et al.
2011
Baseline: Mean Week 7: Mean
Week 14: Mean Mean change
(SD)
(SD)
(SD)
from baseline
CBT group
9.68 (8.03)
6.72 (6.20)
2.24 (3.22)
7.44, p <0.01
Control group
1.33 (3.37)
3.17 (3.16)
2.92 (2.81)
-1.59, p <0.01

In the study conducted by West et al., 69 pediatric subjects were recruited from a
specialty pediatric mood disorders clinic in an urban academic medical center. The subjects were
randomly assigned to either the CBT group or control group and received treatment for a total of
eight weeks.7 The CBT group received weekly CBT and the control group received general
psychotherapy with therapists who were not trained in CBT.7 In addition, the authors of this
study included families in the therapy sessions to help engage the children and help them retain
the information being taught.7 CBDRS and CMRS were performed by their parents at baseline,
weeks 4 and 8 (during treatment), week 12 (post-treatment), and week 39 (follow-up).7
The CBDRS in the CBT group showed improvement with an average change of 9 from
baseline to follow-up at week 39 while the control group only showed an average change of 4
over the same time period. The larger average change in symptom score of CBDRS in the CBT
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group indicates that CBT helped with depressive symptoms more than the control group. The
authors found that this decrease in symptoms with CBT was statistically significant at p<0.007. 7
The CMRS in the CBT group showed improvement with an average change of 6 from
baseline to follow-up at week 39 while the control group only showed an average change of 2
over the same time period. The larger average change in symptom score of CMRS in the CBT
group indicates that CBT helped with manic symptoms more than the control group. The authors
found that this decrease in symptoms with CBT was statistically significant at p<0.03. 7 In
addition, a numbers needed to treat (NNT) of 2 was calculated. This NNT signifies that two
subjects would need to be treated with CBT for one more subject to see a positive effect
compared to the control group.
The study reports that mixed-effects regression models (MRM’s) were conducted via
SPSS MIXED to examine the responses of each outcome.7 The authors also included the intent
to treat analysis indicating that all subjects that were initially enrolled in the study and
randomized to a group were included in the analysis.7
Table 4. Average CBDRS Symptom Scores at Weeks 4, 8, 12, and 39 from Baseline in West
et al.
Baseline Treatment Treatment PostFollow-up Change
Week 4
Week 8
treatment Week 39
from
Week 12
baseline
CBT group
20
18
15
14
11
9, p<0.03
Control group 27
27
24
27
23
4, p<0.03
Table 5. Average CMRS Symptom Scores at Weeks 4, 8, 12, and 39 from Baseline in West
et al.
Baseline Treatment Treatment PostFollow-up Change
Week 4
Week 8
treatment Week 39
from
Week 12
baseline
CBT group
18
18
13
13
12
6, p<0.007
Control
20
19
21
19
18
2, p<0.007
group
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Table 6. NNT for CMRS Calculated Based on the CBT Group and Control Group at Posttreatment
CER
EER
RBI
ABI
NNT
0.21
0.88
3.19
0.67
2

In the study conducted by Costa et al. (2012), 41 subjects were recruited from the
Institute of Psychiatry of the Federal University of Rio de Janeiro. The subjects were evaluated
over a 14-week period while receiving either CBT prescribed by an experienced clinical
psychologist trained in CBT or TAU.8 Each subject in the CBT group attended weekly sessions
lasting two-hours each and focused on educating the patient about their condition and the
treatment process, teaching them methods for monitoring their symptoms and staying compliant
with treatment, and providing them with strategies to cope and manage with stress that ultimately
may lead to worsening symptoms.8 Each subject in the control group attended regular therapy
sessions prescribed by the psychiatrist.8
The BDI for the CBT group showed an average change of 12.28 at week 14 which
indicates that the depressive symptoms improved with treatment. The BDI for the control group
showed an average change of -2.25 at week 14 which indicates that the depressive symptoms
remained the same or worsened with treatment.
The YMRS for the CBT group showed an average change of 7.44 at week 14 which
indicates that the manic symptoms improved with treatment. The YMRS for the control group
showed an average change of -1.59 at week 14 which indicates that the manic symptoms
remained the same or worsened with treatment.
The authors found that this greater decrease of depressive and manic symptoms with
CBT was statistically significant at p<0.01.8 NNT was not calculated for this study because the
data were not dichotomous. The study reports the data were analyzed using Pearson chi-square,

Dorley Bipolar Disorder & CBT 9
Fisher exact tests, statistical analysis of variance, and regression analysis. 8 The authors reported
that CBT was well tolerated and only one subject required hospitalization for reasons not
discussed.
Table 7. Mean ± SD BDI Changes at 7 Weeks and 14 Weeks from Baseline in Costa et al.
2012
Baseline: Mean Week 7: Mean Week 14: Mean Mean change
± SD
± SD
± SD
from baseline
CBT group
19.52 ± 9.79
12.00 ± 7.90
7.24 ± 6.42
12.28, p <0.01
TAU group
11.67 ± 8.39
12.58 ± 8.36
13.92 ± 9.17
-2.25, p <0.01
Table 8. Mean ± SD YMRS Changes at 7 Weeks and 14 Weeks from Baseline in Costa et al.
2012
Baseline: Mean Week 7: Mean Week 14: Mean
Mean change
± SD
± SD
± SD
from baseline
CBT group
9.68 ± 8.03
6.72 ± 6.20
2.24 ± 3.22
7.44, p <0.01
TAU group
1.33 ± 3.37
3.17 ± 3.16
2.92 ± 2.81
-1.59, p <0.01
DISCUSSION
Bipolar disorder is a lifelong condition that can negatively impact the quality of life
especially in populations that don’t have access to proper medical care. Unfortunately, suicide is
common among those with the disorder. Because bipolar disorder usually requires medical
treatment with a combination of pharmacotherapy, psychotherapy, and lifestyle approaches,
compliance often becomes a concern. Medications can be expensive and usually require weeks to
months to build in the system and produce notable effects. In addition, everybody responds to
medications differently and it may take a few medications before finding the one that works best.
Many medications produce undesirable side effects that may lead patients to stop. Attending
psychotherapy can be challenging due to cost, location, access, and timing. Due to these
concerns, many with bipolar disorder get treated as an inpatient until they learn and are
comfortable managing the depressive and manic symptoms on their own.

Dorley Bipolar Disorder & CBT 10
The three trials that were discussed within this EBM review indicate that CBT can be
effective in reducing depressive and manic symptoms in people with bipolar disorder. In the
studies by Costa et al. (2011) and Costa et al. (2012), both the BDI and YMRS results showed a
statistically significant reduction in depressive and manic symptoms over a 14-week period. In
the study by West et al., both the CBDRS and CMRS showed a reduction in depressive and
manic symptoms from baseline to follow-up at 39 weeks. In addition, most of the subjects
throughout each study were able to tolerate CBT with a couple subjects hospitalized for reasons
not discussed. Tolerability is another benefit of CBT when comparing it to pharmacotherapy
because of the possible adverse reactions that medications may produce.
Although there were limitations among each of the studies, the authors felt that the
studies ultimately proved that cognitive behavioral therapy is superior to treatment as usual
whether that be pharmacotherapy, psychotherapy, or both. The biggest limitation among all of
the studies was the number of participants included.6,7,8 Although the studies by Costa et al.
(2011) and Costa et al. (2012) had very few participants withdrawal, the study by West et al. had
a large number of people withdrawal which weakens the strength of the study. In Costa et al.
(2011) and Costa et al. (2012), the age groups ranged from young adult to middle aged which
can create limitations because bipolar disorder presents differently with age. In addition, bipolar
I, bipolar II, and cyclothymic disorder all present differently but the studies6,7,8 did not specify
which type the subjects had. In all three of the studies,6,7,8 none of the participants included had
severe depression and mania symptoms so it is unknown if CBT will produce a similar reduction
in symptoms. Although double-blinding in CBT trials cannot be done, none of the studies6,7,8
single-blinded the raters which impacts the validity because it can create bias. Because there are
very few studies that focus on CBT for depressive and manic symptoms associated with bipolar
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disorder, these studies produced clinically significant information that can help researchers
determine a foundation for future studies and clinicians with managing their patients.
CONCLUSIONS
This systematic review provided insight into three studies that used cognitive behavioral
therapy for the treatment of depressive and manic symptoms associated with bipolar disorder.
Because all three studies showed clinically significant results, it was determined that cognitive
behavioral therapy is effective at reducing depressive and manic symptoms when compared to
treatment as usual which could include general psychotherapy, pharmacological treatment, or
both. Mental health illnesses are becoming more recognized across all health care fields so
various treatment options are being tested to determine efficacy and benefit. Although, there will
never be one method listed as the gold standard for the treatment of any mental health condition,
treatment should be approached with multiple methods. Each patient should be treated
individually with a combination of pharmacological, psychotherapy (including CBT), and
lifestyle changes. More research needs to be conducted on cognitive behavioral therapy to
ultimately determine the efficacy of this treatment method especially compared to
pharmacotherapy which is a major method of treatment. Future studies should focus on
increasing the number of participants to help strengthen the study and ensure the data analyzed is
more accurate. In addition, there should be focus on patients with severe mania and depression,
different age groups, male versus female patients, and different socioeconomic classes to
determine which groups benefit most from CBT. Researchers should also increase therapy
sessions to multiple times per week especially in those with more severe bipolar symptoms.
Bipolar disorder is a complex disorder and each patient should be treated with an individualized
plan that is best tailored to their lifestyle.
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